Powered by

Fennec Pharmaceuticals rises to test 4.0 February 27, 2017 17:00 EST

Feb 27, 2017 - News Bites Canadian Markets


Fennec Pharmaceuticals Inc. (TSX:FRX), Canada's 24th largest Biotechnology company by market cap, rebounded after hitting a low for the day of CAD3.84 and rose back to test the 4.0 hurdle. The stock price has soared 55.0c (15.5%) from its last trading session of February 24., compared with the S&P/TSX 60 Index which fell 2.5 points (0.3%) in the day for a relative price increase of 15.8%. The volume was 0.2 times the average daily trading volume of 42,416 shares

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox